Abiraterone Mylan Unione Europea - croato - EMA (European Medicines Agency)

abiraterone mylan

mylan ireland limited - abirateron acetat - prostatske neoplazme - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Sugammadex Mylan Unione Europea - croato - EMA (European Medicines Agency)

sugammadex mylan

mylan ireland limited - sugammadex sodium - neuromuskularna blokada - svi ostali terapeutski proizvodi - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sitagliptin / Metformin hydrochloride Mylan Unione Europea - croato - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. trostruki kombinovanu terapiju) kao dodatak prehrani i vježbe kod pacijenata, nedovoljno kontroliranim o njihovo maksimalno переносимой doze метформина i sulfonilurejom. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

AMOKSICILIN/KLAVULANSKA KISELINA APTAPHARMA 1000 mg/1 bočica+ 200 mg/1 bočica prašak za rastvor za injekciju ili infuziju Bosnia Erzegovina - croato - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

amoksicilin/klavulanska kiselina aptapharma 1000 mg/1 bočica+ 200 mg/1 bočica prašak za rastvor za injekciju ili infuziju

pharmavision bh d.o.o. - amoksicilin, klavulanska kiselina - prašak za rastvor za injekciju ili infuziju - 1000 mg/1 bočica+ 200 mg/1 bočica - jedna bočica sadrži 1000 mg amoksicilina u obliku amoksicilin natrijuma i 200 mg klavulanske kiseline u obliku kalijum klavulanata.

BONNEDRA 150 mg/1 tableta filmom obložena tableta Bosnia Erzegovina - croato - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

bonnedra 150 mg/1 tableta filmom obložena tableta

pliva d.o.o.sarajevo - ibandronska kiselina - filmom obložena tableta - 150 mg/1 tableta - 1 filmom obložena tableta sadrži: 150 mg ibandronske kiseline (u obliku ibandronatnatrijum, monohidrata)

Zeffix Unione Europea - croato - EMA (European Medicines Agency)

zeffix

glaxosmithkline (ireland) limited - lamivudin - hepatitis b, kronični - antivirusni lijekovi za sustavnu uporabu - zeffix is indicated for the treatment of chronic hepatitis b in adults with: , compensated liver disease with evidence of active viral replication, persistently elevated serum alanine aminotransferase (alt) levels and histological evidence of active liver inflammation and / or fibrosis. početak liječenja lamivudinom mora biti samo u slučaju, ako se korištenje alternativnih antivirusnih agenata s višim genetski barijera nisu dostupni ili odgovarajući;, декомпенсированной bolesti jetre u kombinaciji s drugi agent bez križne rezistencije na lamivudin.

Avamys Unione Europea - croato - EMA (European Medicines Agency)

avamys

glaxosmithkline (ireland) limited - flutikazon furoat - rhinitis, allergic, seasonal; rhinitis, allergic, perennial - nosni lijekovi, kortikosteroidi, - odrasli, adolescenti (12 i više godina) i djeca (6-11 godina). avamys je indiciran za liječenje simptoma alergijskog rinitisa.